Assessment of Quizartinib Pharmacokinetic in Subjects With Severe Hepatic Impairment
Recruiting now · Phase 1
Conditions studied: Hepatic Impairment
In brief
This study will evaluate and compare the PK in subjects with severe HI to that of matched healthy control subjects with normal hepatic function.
Key facts
- Study ID
- NCT06740799
- Run by
- Daiichi Sankyo
- People needed
- 12
- Starts
- 2024-09-30
- Expected to finish
- 2026-10-31
- Last updated by the study team
- 2026-04-01
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: accepted.
Where it is running
- Clinical Pharmacology of Miami, LLC — Miami, Florida, United States (enrolling)
- Advanced Pharma — Miami, Florida, United States (enrolling)
- GCP Research — St. Petersburg, Florida, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.